The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Correlation of immune remodeling linked to obesity with immunotherapy outcomes in cholangiocarcinoma: An externally validated international cohort study.
 
Antonella Cammarota
No Relationships to Disclose
 
Fen Saj
No Relationships to Disclose
 
Behnaz Bozorgui
No Relationships to Disclose
 
Iwan Paolucci
Stock and Other Ownership Interests - Intuitive Surgical; SOPHiA Genetics
Travel, Accommodations, Expenses - Siemens Healhineers/Varian Medical Systems
 
Quentin Kimana
No Relationships to Disclose
 
Nakul Shah
No Relationships to Disclose
 
Sangeeta Goswami
No Relationships to Disclose
 
Lawrence Kwong
No Relationships to Disclose
 
Anil Korkut
Stock and Other Ownership Interests - Vivoz Biolabs LLC (I)
Research Funding - BostonGene
Patents, Royalties, Other Intellectual Property - Drug combinations for treatment of melanoma and other cancers C Sander, A Korkut, , A Korkut US Patent App. 14/722,768 (Inst); Systems and methods for identifying drug combinations for reduced drug resistance in cancer treatment C Sander, A Korkut US Patent App. 14/722,733 (Inst)
 
Justin Nguyen
No Relationships to Disclose
 
Elisabeth Kong
No Relationships to Disclose
 
Rita Balsano
Honoraria - AstraZeneca
Travel, Accommodations, Expenses - Roche
 
Francesca Salani
Honoraria - AstraZeneca; Bristol-Myers Squibb; Daiichi Sankyo; Eisai; Roche
Consulting or Advisory Role - AstraZeneca
Travel, Accommodations, Expenses - Leo Pharma
 
Caterina Vivaldi
Consulting or Advisory Role - AstraZeneca; Eisai/MSD; Incyte; Roche; Taiho Oncology
Speakers' Bureau - Amgen; AstraZeneca; BMS; Eisai; MSD; SERVIER
Travel, Accommodations, Expenses - AstraZeneca; MSD; Roche
 
Margherita Rimini
No Relationships to Disclose
 
Lorenzo Fornaro
Honoraria - AstraZeneca; BMS GmbH & Co. KG; Daiichi Sankyo/Astra Zeneca; MSD; SERVIER
Consulting or Advisory Role - Astellas Pharma; AstraZeneca/Daiichi Sankyo; BeiGene; MSD; SERVIER; Taiho Pharmaceutical
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); BeiGene (Inst); BMS GmbH & Co. KG (Inst); Daiichi Sankyo/Astra Zeneca (Inst); Incyte (Inst); Janssen (Inst); Merck Sharp & Dohme (Inst); Nucana (Inst); Roche (Inst)
Travel, Accommodations, Expenses - MSD; SERVIER
 
Andrea Casadei-Gardini
Honoraria - AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; Incyte; Ipsen
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; Incyte; Ipsen; IQVIA; MSD; Roche; SERVIER
Research Funding - AstraZeneca (Inst); Eisai (Inst)
 
Ana Lleo
Honoraria - Advanz Pharma; Alfasigma; AstraZeneca; Gilead Sciences; GlaxoSmithKline; GORE; Incyte; Ipsen
Consulting or Advisory Role - Advanz Pharma; AstraZeneca; Dr Falk Pharma UK Ltd; Gilead Sciences; GlaxoSmithKline; Ipsen; Mirum Pharmaceuticals
 
Milind Javle
Honoraria - AstraZeneca/MedImmune; EMD Serono/Merck; Incyte; Merck; QED Therapeutics; TransThera Biosciences
Consulting or Advisory Role - AstraZeneca; Basilea Pharmaceutical; EMD Serono; incyte; Merck; Mundipharma; oncosil; QED Therapeutics
Other Relationship - Bayer; BeiGene; Incyte; Merck; Merck Serono; Novartis; Pieris Pharmaceuticals; QED Therapeutics; Rafael Pharmaceuticals; Seagen
 
Lorenza Rimassa
Honoraria - Abbvie; Amgen; AstraZeneca; AstraZeneca; Bayer; Biologix FZC; Bristol-Myers Squibb Italy; Eisai; Eisai; Gilead Sciences; Guerbet; Incyte; Ipsen; Lilly; Merck Serono; Roche; Sanofi; SERVIER
Consulting or Advisory Role - Abbvie; Amgen; ArQule; AstraZeneca; Basilea; Baxter; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Bristol-Myers Squibb; Celgene; Eisai; Eisai; Elevar Therapeutics; Exelixis; Genenta Science; Guerbet; Hengrui Therapeutics; Incyte; Ipsen; IQvia; Italfarmaco; Jazz Pharmaceuticals; Lilly; Merck Sharp & Dohme; Nerviano Medical Sciences; Roche; Sanofi; SERVIER; Sirtex Medical; Taiho Oncology; Zymeworks; Zymeworks
Research Funding - Abbvie (Inst); Agios (Inst); ARMO BioSciences (Inst); ArQule (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); BeiGene (Inst); Bristol-Myers Squibb Company (Inst); Eisai (Inst); Exelixis (Inst); Exelixis/Ipsen (Inst); FibroGen (Inst); Incyte (Inst); Ipsen (Inst); Jazz Pharmaceuticals; Lilly (Inst); Merck Sharp & Dohme (Inst); Nerviano Medical Sciences (Inst); Roche; SERVIER (Inst); Taiho Oncology (Inst); TransThera Sciences (Nanjing), Inc. (Inst); Zymeworks (Inst)
Travel, Accommodations, Expenses - ArQule; AstraZeneca; Ipsen; SERVIER